Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation (AF) (Code-AF Trial)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20,000
- 试验地点
- 1
- 主要终点
- number of hospitalization by heart failure
研究概览
简要总结
This study is prospective Cohort study which was performed in multicenter (General Hospital) in Korea. Inclusion criteria is all patients with atrial fibrillation who visit hospital. The purpose is to analyze complication, composite outcome (all cause mortality, hospitalization, the incidence of stroke, heart failure and cardiovascular event (MACE)) according to the 1) the use of anti-arrhythmic drugs (AADs), 2) use of medication for rate control (beta blocker, calcium channel blocker and digoxin) and 3) use of anticoagulation agents (warfarin, coumadin, an NOAC)
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 19 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients with atrial fibrillation
- •patients with age more than 19
- •patients who agree with study inclusion
排除标准
- •patients who do not agree with study inclusion
- •patients with age less than 19
- •Pregnancy, Breastfeeding
结局指标
主要结局
number of hospitalization by heart failure
时间窗: 3 years
number of recurrent stroke
时间窗: 3 years
number of cardiovascular events
时间窗: 3 years
all cause mortality
时间窗: 3 years
次要结局
未报告次要终点
